Gentile A - Search Results

1

Gentile A, Comoglio PM. Gentile A, et al. Int J Dev Biol. 2004;48(5-6):451-6. doi: 10.1387/ijdb.041799ag. Int J Dev Biol. 2004. PMID: 15349819 Free article. Review.

2

The Met tyrosine kinase receptor in development and cancer.

Gentile A, Trusolino L, Comoglio PM. Gentile A, et al. Cancer Metastasis Rev. 2008 Mar;27(1):85-94. doi: 10.1007/s10555-007-9107-6. Cancer Metastasis Rev. 2008. PMID: 18175071 Review.

3

The ROR1 pseudokinase diversifies signaling outputs in MET-addicted cancer cells.

Gentile A, Lazzari L, Benvenuti S, Trusolino L, Comoglio PM. Gentile A, et al. Int J Cancer. 2014 Nov 15;135(10):2305-16. doi: 10.1002/ijc.28879. Epub 2014 Apr 15. Int J Cancer. 2014. PMID: 24706440

4

Osteopontin is an autocrine mediator of hepatocyte growth factor-induced invasive growth.

Medico E, Gentile A, Lo Celso C, Williams TA, Gambarotta G, Trusolino L, Comoglio PM. Medico E, et al. Among authors: gentile a. Cancer Res. 2001 Aug 1;61(15):5861-8. Cancer Res. 2001. PMID: 11479227

5

Met-driven invasive growth involves transcriptional regulation of Arhgap12.

Gentile A, D'Alessandro L, Lazzari L, Martinoglio B, Bertotti A, Mira A, Lanzetti L, Comoglio PM, Medico E. Gentile A, et al. Oncogene. 2008 Sep 18;27(42):5590-8. doi: 10.1038/onc.2008.173. Epub 2008 May 26. Oncogene. 2008. PMID: 18504429 Free article.

6

Ron kinase transphosphorylation sustains MET oncogene addiction.

Benvenuti S, Lazzari L, Arnesano A, Li Chiavi G, Gentile A, Comoglio PM. Benvenuti S, et al. Among authors: gentile a. Cancer Res. 2011 Mar 1;71(5):1945-55. doi: 10.1158/0008-5472.CAN-10-2100. Epub 2011 Jan 6. Cancer Res. 2011. PMID: 21212418 Free article.

7

Ror1 is a pseudokinase that is crucial for Met-driven tumorigenesis.

Gentile A, Lazzari L, Benvenuti S, Trusolino L, Comoglio PM. Gentile A, et al. Cancer Res. 2011 Apr 15;71(8):3132-41. doi: 10.1158/0008-5472.CAN-10-2662. Epub 2011 Apr 12. Cancer Res. 2011. PMID: 21487037 Free article.

8

An 'in-cell trial' to assess the efficacy of a monovalent anti-MET antibody as monotherapy and in association with standard cytotoxics.

Benvenuti S, Gentile A, Lazzari L, Arnesano A, Trusolino L, Comoglio PM. Benvenuti S, et al. Among authors: gentile a. Mol Oncol. 2014 Mar;8(2):378-88. doi: 10.1016/j.molonc.2013.12.006. Epub 2013 Dec 18. Mol Oncol. 2014. PMID: 24389243 Free PMC article.

9

MET Activation and Physical Dynamics of the Metastatic Process: The Paradigm of Cancers of Unknown Primary Origin.

Stella GM, Benvenuti S, Gentile A, Comoglio PM. Stella GM, et al. Among authors: gentile a. EBioMedicine. 2017 Oct;24:34-42. doi: 10.1016/j.ebiom.2017.09.025. Epub 2017 Sep 21. EBioMedicine. 2017. PMID: 29037604 Free PMC article. Review.

10

Whole exome sequencing identifies a germline MET mutation in two siblings with hereditary wild-type RET medullary thyroid cancer.

Sponziello M, Benvenuti S, Gentile A, Pecce V, Rosignolo F, Virzì AR, Milan M, Comoglio PM, Londin E, Fortina P, Barnabei A, Appetecchia M, Marandino F, Russo D, Filetti S, Durante C, Verrienti A. Sponziello M, et al. Among authors: gentile a. Hum Mutat. 2018 Mar;39(3):371-377. doi: 10.1002/humu.23378. Epub 2017 Dec 20. Hum Mutat. 2018. PMID: 29219214

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

913 results

Search Page

Filters